1. Home
  2. ASRT vs BRID Comparison

ASRT vs BRID Comparison

Compare ASRT & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • BRID
  • Stock Information
  • Founded
  • ASRT 1995
  • BRID 1932
  • Country
  • ASRT United States
  • BRID United States
  • Employees
  • ASRT N/A
  • BRID N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • BRID Specialty Foods
  • Sector
  • ASRT Health Care
  • BRID Consumer Staples
  • Exchange
  • ASRT Nasdaq
  • BRID Nasdaq
  • Market Cap
  • ASRT 79.1M
  • BRID 72.8M
  • IPO Year
  • ASRT 1997
  • BRID N/A
  • Fundamental
  • Price
  • ASRT $0.82
  • BRID $7.96
  • Analyst Decision
  • ASRT Strong Buy
  • BRID
  • Analyst Count
  • ASRT 1
  • BRID 0
  • Target Price
  • ASRT $3.00
  • BRID N/A
  • AVG Volume (30 Days)
  • ASRT 195.7K
  • BRID 3.2K
  • Earning Date
  • ASRT 11-10-2025
  • BRID 08-22-2025
  • Dividend Yield
  • ASRT N/A
  • BRID N/A
  • EPS Growth
  • ASRT N/A
  • BRID N/A
  • EPS
  • ASRT N/A
  • BRID N/A
  • Revenue
  • ASRT $117,099,000.00
  • BRID $227,364,000.00
  • Revenue This Year
  • ASRT N/A
  • BRID N/A
  • Revenue Next Year
  • ASRT $4.10
  • BRID N/A
  • P/E Ratio
  • ASRT N/A
  • BRID N/A
  • Revenue Growth
  • ASRT N/A
  • BRID N/A
  • 52 Week Low
  • ASRT $0.51
  • BRID $7.28
  • 52 Week High
  • ASRT $1.12
  • BRID $10.83
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 44.03
  • BRID 51.30
  • Support Level
  • ASRT $0.81
  • BRID $7.53
  • Resistance Level
  • ASRT $0.85
  • BRID $8.62
  • Average True Range (ATR)
  • ASRT 0.04
  • BRID 0.24
  • MACD
  • ASRT -0.01
  • BRID 0.03
  • Stochastic Oscillator
  • ASRT 28.16
  • BRID 48.03

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

Share on Social Networks: